796 OUTCOMES OF DELAYED SURGERY IN PATIENTS WITH RESIDUAL DISEASE AFTER NEOADJUVANT CHEMORADIOTHERAPY FOR OESOPHAGEAL CANCER
Hidde Overtoom(Erasmus MC), J. Jan B. van Lanschot(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), Ben M. Eyck(Erasmus MC Cancer Institute), Bas P. L. Wijnhoven(Inserm), Pieter C. van der Sluis(University Medical Center Utrecht), Berend Jan van der Wilk(Erasmus MC), Bo Jan Noordman(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Extended Transthoracic Resection Compared with Limited Transhiatal Resection for Adenocarcinoma of the Esophagus
|New England Journal of Medicine|2002|1.6k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709